11:22 AM EDT, 09/15/2023 (MT Newswires) -- European equities traded in the US as American depositary receipts closed out the week lower Friday, falling 0.5% to 1,218.14 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company MorphoSys (MOR), which rose 1.3% and 2% respectively. They were followed by hotel booking site trivago (TRVG) and biopharmaceutical company Cellectis (CLLS), which were up 3.2% and 1.8% respectively.

The decliners from continental Europe were led by internet browser company Opera (OPRA) and telecommunications company Nokia (NOK), which fell 2.7% and 2% respectively. They were followed by financial services company Banco Santander (SAN) and biotech firm Biophytis (BPTS), which were down 1.5% and 2.2% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX), which climbed 4.7%, followed by insurance company Prudential (PUK) and biotech firm Autolus Therapeutics (AUTL), which were up 1.4% and 0.7% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and biotech firm Trinity Biotech (TRIB), which fell 6.3% and 0.8% respectively. They were followed by biopharmaceutical company Verona Pharma (VRNA), which dropped 1.9%.

http://www.mtnewswires.com
Copyright © 2023 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.